GEIST:UPC Searchengine

ORD_598363/2023

Regeneron Pharmaceuticals Inc. v. Amgen Inc.

Date
2024-07-16
Division
Munich (DE) Central Division - Section
Type of action
Counterclaim for revocation
Language
EN

Metadata

Case IDORD_598363-2023-855a61408692
Case number
Registry numberORD_598363/2023
Order referenceORD_598363/2023
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 53

1 DECISION of the Court of First Instance of the Unified Patent Court Central division (Section Munich) delivered on 16 July 2024 concerning EP 3 666 797 B1 HEADNOTES: 1. When interpreting a patent claim, the person skilled in the art does not apply a philological understanding, but determines the technical meaning of the terms used with the aid of the description and the drawings. From the function of the individual features in the context of the patent claim as a whole, it must be deduced which technical function these features actually have individually and as a whole. The patent description may represent a patent´s own lexicon. 2. A claimed invention is to be conside red the “same invention” as meant in Article 87 EPC (priority right) if the skilled person can derive the subject-matter ...